← Back to patent-cliff list
CAS 541-41-3
Carbonochloridic acid ethyl esterethyl carbonochloridateChloridocarbonic acid ethyl ester
Codes: (II)461018-4-a, EFAV-028, Tamsulosin Hydrochloride-088, SOLIF-002, SIME-015, IVAC-011, AZILS-006, S-pantoprazole sodium-057, LINE-012
Application context (from source-drug indications)
Waldenström macroglobulinaemiaIbrutinibChronic lymphocytic leukaemiaIbrutinibMantle cell lymphomaIbrutinibGraft-versus-host diseaseIbrutinibHIV infectionEfavirenz/Lamivudine/Tenofovir Disoproxil FumarateErectile dysfunctionTadalafil/TamsulosinBenign prostatic hyperplasiaTadalafil/TamsulosinLower urinary tract symptomsSolifenacin Succinate/Tamsulosin HydrochlorideBenign prostatic hyperplasiaSolifenacin Succinate/Tamsulosin HydrochlorideOveractive bladderSolifenacin Succinate/Tamsulosin HydrochlorideDrug-related adverse effects and reactionsSolifenacin Succinate/Tamsulosin HydrochlorideBladder neck obstructionSolifenacin Succinate/Tamsulosin HydrochlorideHepatitis CSimeprevir SodiumChronic hepatitis CSimeprevir SodiumMeaslesSimeprevir SodiumMycobacterium tuberculosis infectionSimeprevir SodiumCystic fibrosisIvacaftorChronic bronchitisIvacaftorChronic obstructive pulmonary diseaseIvacaftorSinusitisIvacaftorHypertensionAzilsartanEssential hypertensionAzilsartanType 2 diabetesAzilsartanObesityAzilsartanDiabetesAzilsartanBenign prostatic hyperplasiaDutasteride/Tamsulosin HydrochlorideGastro-oesophageal reflux diseaseS-pantoprazole sodiumPeptic ulcerS-pantoprazole sodiumHaemorrhageS-pantoprazole sodiumTrauma and injuryS-pantoprazole sodiumComaS-pantoprazole sodiumAspiration pneumoniaS-pantoprazole sodiumBenign prostatic hyperplasiaTamsulosin HydrochlorideUrinary tract infectionTamsulosin HydrochlorideUrinary retentionTamsulosin HydrochlorideInguinal herniaTamsulosin HydrochlorideVoiding dysfunctionTamsulosin HydrochlorideLower urinary tract symptomsTamsulosin HydrochlorideHIV infectionEfavirenzCreutzfeldt-Jakob diseaseEfavirenzAlzheimer's diseaseEfavirenzPancreatic cancerEfavirenzProstate cancerEfavirenzNon-Hodgkin lymphomaEfavirenzOveractive bladderSolifenacin SuccinateUrge incontinenceSolifenacin SuccinateUrinary tract diseaseSolifenacin Succinate非复杂性皮肤和皮肤结构感染LinezolidPneumoniaLinezolidComplicated skin and skin structure infectionLinezolidBacteraemiaLinezolidBacterial infectionLinezolidHealthcare-associated pneumoniaLinezolid
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Ibrutinib | Tier A — Act now | 2027 |
| Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate | Tier C — Watch / trade | - |
| Tadalafil/Tamsulosin | Tier C — Watch / trade | - |
| Solifenacin Succinate/Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
| Simeprevir Sodium | Tier B — Position early | - |
| Ivacaftor | Tier B — Position early | - |
| Azilsartan | Tier C — Watch / trade | - |
| Dutasteride/Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
| S-pantoprazole sodium | Tier C — Watch / trade | - |
| Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
| Efavirenz | Tier B — Position early | - |
| Solifenacin Succinate | Tier B — Position early | - |
| Linezolid | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-(Phenyloxy)benzoic acid→Carbonochloridic acid ethyl ester→Ethyl 4-phenoxybenzoyl carbonate→1,1-Dicyanomethane→3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine→(4-Phenoxybenzoyl)malononitrile→[Chloro(4-phenoxyphenyl)methylene]malononitrile→3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole→Formamidine acetate→3-Chloro-1H-pyrazolo[3,4-d]pyrimidin-4-amine→3-Bromo-1H-pyrazolo[3,4-d]pyrimidin-4-amine→3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine→4-Amino-1H-pyrazolo[3,4-d]pyrimidin-3-ylmethanesulfonate
ethynylcyclopropane→1-(2-amino-5-chlorophenyl)-2,2,2-trifluoroethanone hydrochloride→ethyl carbonochloridate→ethyl (4-chloro-2-(2,2,2-trifluoroacetyl)phenyl)carbamate→(1R,2R)-2-(benzyl(methyl)amino)-3-(tert-butoxy)-1-(4-nitrophenyl)propan-1-ol→(1R,2R)-2-(benzyl(methyl)amino)-1-(4-nitrophenyl)propane-1,3-diol→2-methylprop-1-ene
5-Acetyl-2-methoxybenzene-1-sulfonamide→2-(2-Ethoxyphenoxy)ethylamine→Tamsulosin Hydrochloride-085→(2R)-Hydroxy(phenyl)acetic acid 5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzene-1-sulfonamide→(S)-1-(tert-Butoxycarbonyl)pyrrolidine-2-carboxylic acid→Carbonochloridic acid ethyl ester→Ethoxycarbonyl 1-(tert-butoxycarbonyl)-L-prolinate→2-Methoxydibenzo[b,d]furan-3-amine→tert-Butyl (2S)-2-[(2-methoxydibenzo[b,d]furan-3-yl)carbamoyl]pyrrolidine-1-carboxylate→N-(2-Methoxydibenzo[b,d]furan-3-yl)-L-prolinamide
5-Acetyl-2-methoxybenzene-1-sulfonamide→2-(2-Ethoxyphenoxy)ethylamine→Tamsulosin Hydrochloride-085→(2R)-Hydroxy(phenyl)acetic acid 5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzene-1-sulfonamide→(S)-1-(tert-Butoxycarbonyl)pyrrolidine-2-carboxylic acid→Carbonochloridic acid ethyl ester→Ethoxycarbonyl 1-(tert-butoxycarbonyl)-L-prolinate→2-Methoxydibenzo[b,d]furan-3-amine→tert-Butyl (2S)-2-[(2-methoxydibenzo[b,d]furan-3-yl)carbamoyl]pyrrolidine-1-carboxylate→N-(2-Methoxydibenzo[b,d]furan-3-yl)-L-prolinamide
N-methylhex-5-en-1-amine→2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-ol→(1R,2S)-ethyl 1-((1R,2R,4R)-2-(hex-5-en-1-yl(methyl)carbamoyl)-4-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)cyclopentanecarboxamido)-2-vinylcyclopropanecarboxylate→tetraethyl butane-1,2,3,4-tetracarboxylate→4-oxocyclopentane-1,2-dicarboxylic acid→4-hydroxycyclopentane-1,2-dicarboxylic acid→4-hydroxycyclopentane-1,2-dicarboxylic acid→ethyl carbonochloridate→3-oxo-2-oxabicyclo[2.2.1]heptane-5-carboxylic acid→(1S,4R,5R)-benzyl 3-oxo-2-oxabicyclo[2.2.1]heptane-5-carboxylate→butane-1,2,3,4-tetracarboxylic acid→(1R,2R,4R)-1-benzyl 2-methyl 4-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)cyclopentane-1,2-dicarboxylate→(1R,2R,4S)-4-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-2-(methoxycarbonyl)cyclopentanecarboxylic acid→(1R,2R,4S)-methyl 2-(hex-5-en-1-yl(methyl)carbamoyl)-4-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)cyclopentanecarboxylate→lithium (1R,2R,4S)-2-(hex-5-en-1-yl(methyl)carbamoyl)-4-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)cyclopentanecarboxylate→(1R,2S)-ethyl 1-amino-2-vinylcyclopropanecarboxylate
2,4-di-tert-butylphenol→ethyl carbonochloridate→2,4-di-tert-butylphenyl ethyl carbonate→2,4-di-tert-butyl-5-nitrophenyl ethyl carbonate→5-amino-2,4-di-tert-butylphenyl ethyl carbonate→4-oxo-1,4-dihydroquinoline-3-carbonyl chloride→2,4-di-tert-butyl-5-(4-oxo-1,4-dihydroquinoline-3-carboxamido)phenyl ethyl carbonate
methyl 2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)-3-nitrobenzoate→methyl 3-amino-2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)benzoate→triethoxymethoxyethane→methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate→methyl (Z)-2-ethoxy-1-((2'-(N'-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate→ethyl carbonochloridate→methyl (Z)-2-ethoxy-1-((2'-(N'-((ethoxycarbonyl)oxy)carbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate→methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
5-Acetyl-2-methoxybenzene-1-sulfonamide→2-(2-Ethoxyphenoxy)ethylamine→Tamsulosin Hydrochloride-085→(2R)-Hydroxy(phenyl)acetic acid 5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzene-1-sulfonamide→(S)-1-(tert-Butoxycarbonyl)pyrrolidine-2-carboxylic acid→Carbonochloridic acid ethyl ester→Ethoxycarbonyl 1-(tert-butoxycarbonyl)-L-prolinate→2-Methoxydibenzo[b,d]furan-3-amine→tert-Butyl (2S)-2-[(2-methoxydibenzo[b,d]furan-3-yl)carbamoyl]pyrrolidine-1-carboxylate→N-(2-Methoxydibenzo[b,d]furan-3-yl)-L-prolinamide
2-(Chloromethyl)-3,4-dimethoxypyridine hydrogen chloride→Aminothiocarboxamide→(3,4-Dimethoxypyridin-2-yl)methyl hydrosulfide→Chloridocarbonic acid ethyl ester→Ethyl (3,4-dimethoxy-2-pyridyl)methylsulfanylformate→1,2-Diamino-4-(difluoromethoxy)benzene→5-(Difluoromethoxy)-2-(3,4-dimethoxypyridin-2-ylmethylsulfanyl)-1H-benzimidazole→5-(Difluoromethoxy)-2-(3,4-dimethoxypyridin-2-ylmethylsulfinyl)-1H-benzimidazole
5-Acetyl-2-methoxybenzene-1-sulfonamide→2-(2-Ethoxyphenoxy)ethylamine→Tamsulosin Hydrochloride-085→(2R)-Hydroxy(phenyl)acetic acid 5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzene-1-sulfonamide→(S)-1-(tert-Butoxycarbonyl)pyrrolidine-2-carboxylic acid→Carbonochloridic acid ethyl ester→Ethoxycarbonyl 1-(tert-butoxycarbonyl)-L-prolinate→2-Methoxydibenzo[b,d]furan-3-amine→tert-Butyl (2S)-2-[(2-methoxydibenzo[b,d]furan-3-yl)carbamoyl]pyrrolidine-1-carboxylate→N-(2-Methoxydibenzo[b,d]furan-3-yl)-L-prolinamide
ethynylcyclopropane→1-(2-amino-5-chlorophenyl)-2,2,2-trifluoroethanone hydrochloride→ethyl carbonochloridate→ethyl (4-chloro-2-(2,2,2-trifluoroacetyl)phenyl)carbamate→(1R,2R)-2-(benzyl(methyl)amino)-3-(tert-butoxy)-1-(4-nitrophenyl)propan-1-ol→(1R,2R)-2-(benzyl(methyl)amino)-1-(4-nitrophenyl)propane-1,3-diol→2-methylprop-1-ene
3-fluoro-4-morpholinoaniline→N-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-3-fluoro-4-morpholinoaniline→N-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-3-fluoro-4-morpholinoaniline→ethyl carbonochloridate→ethyl ((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)(3-fluoro-4-morpholinophenyl)carbamate→ethyl (2,3-dihydroxypropyl)(3-fluoro-4-morpholinophenyl)carbamate→ethyl (3-fluoro-4-morpholinophenyl)(2-oxoethyl)carbamate→(R)-N-((R)-1-hydroxy-4-methyl-1,1-diphenylpentan-2-yl)pyrrolidine-2-carboxamide→ethyl (S)-(3-fluoro-4-morpholinophenyl)(2-hydroxy-4-oxopentyl)carbamate→ethyl (S,E)-(3-fluoro-4-morpholinophenyl)(2-hydroxy-4-(hydroxyimino)pentyl)carbamate→(S,E)-3-(3-fluoro-4-morpholinophenyl)-5-(2-(hydroxyimino)propyl)oxazolidin-2-one
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.